Showing results (121-130 of 216) with videos related to
Sort By:
Pageof 22
Journal for Immunotherapy of Cancer|June 13, 2024
HDL-cholesterol confers sensitivity of immunotherapy in nasopharyngeal carcinoma via remodeling tumor-associated macrophages towards the M1 phenotypeFan Luo, Jiaxin Cao, Qun Chen, et al.International Journal of Epidemiology|June 21, 2019
Education and lung cancer: a Mendelian randomization studyHuaqiang Zhou, Yaxiong Zhang, Jiaqing Liu, et al.Medcomm|June 4, 2024
Influence of TP53 mutation on efficacy and survival in advanced EGFR-mutant non-small cell lung cancer patients treated with third-generation EGFR tyrosine kinase inhibitorsZhonghan Zhang, Jinhui Xue, Yunpeng Yang, et al.Genes & Diseases|June 22, 2026
8-Chloroadenosine suppresses hepatocellular carcinoma progression via ADAR1/PPARγ axis-mediated lipid metabolismJing Liu, Yongle Zhao, Xue Gong, et al.Medcomm|November 12, 2021
Incidence and risk factors of second primary cancer after the initial primary human papillomavirus related neoplasmsJiayi Shen, Huaqiang Zhou, Jiaqing Liu, et al.Frontiers in Immunology|June 14, 2023
Continuation of anti-PD-1 therapy plus physician-choice treatment beyond first progression is not associated with clinical benefit in patients with advanced non-small cell lung cancerYixing Wang, Sha Fu, Xuanye Zhang, et al.Cancer Research|September 28, 2022
Sustained Aurora Kinase B Expression Confers Resistance to PI3K Inhibition in Head and Neck Squamous Cell CarcinomaPooja A Shah, Vaishnavi Sambandam, Anne M Fernandez, et al.Cancer Chemotherapy and Pharmacology|August 3, 2022
Paclitaxel exposure-toxicity analysis reveals a pharmacokinetic determinant for dose-limiting neutropenia in East-Asian solid tumor patients: results from two prospective, phase II studiesJinhui Xue, Haipeng He, Zuan Lin, et al.Frontiers in Oncology|February 8, 2021
Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 TherapyLi-Na He, Xuanye Zhang, Haifeng Li, et al.Clinical Lung Cancer|April 30, 2015
Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung CancerXiaobo He, Ting Zhou, Yunpeng Yang, et al.Pageof 22